EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort study

Thomas E Rohan, Yihong Wang, Fergus Couch, Heather Spencer Feigelson, Robert T Greenlee, Stacey Honda, Azadeh Stark, Dhananjay Chitale, Chenxin Zhang, Xiaonan Xue, Mindy Ginsberg, Olivier Loudig

Breast Cancer Research and Treatment · 2025

DOI: 10.1007/s10549-024-07599-x ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Breast Cancer Research and Treatment, 2025. Verfasst von Thomas E Rohan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. thomas.rohan@einsteinmed.edu. Hauptthemen laut MEDLINE: Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, National Cancer Institute/National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To study the association between clinicopathologic characteristics of ductal carcinoma in situ (DCIS) and risk of subsequent invasive breast cancer (IBC).

Methods

We conducted a case–control study nested in a multicenter, population-based cohort of 8175 women aged ≥ 18 years with DCIS diagnosed between 1987 and 2016 and followed for a median duration of 83 months. Cases (n = 497) were women with a first diagnosis of DCIS who developed a subsequent IBC ≥ 6 months later; controls (2/case; n = 959) were matched to cases on age at and calendar year of DCIS diagnosis. Univariable and multivariable conditional logistic regression models were used to examine the associations between the DCIS characteristics of interest (non-screen detection of DCIS, tumor size, positive margins, grade of DCIS, necrosis, architectural pattern, microcalcification, and estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) status) and risk of IBC.

Results

In the total study population, the associations were largely null. In subgroup analyses, there were strong position associations with punctate necrosis (pre/perimenopausal women), detection by physical exam (postmenopausal women), architectural patterns other than the main types (breast-conserving surgery [BCS]), and DCIS margins (ipsilateral cases), and inverse associations with HER2 positivity (BCS) and microcalcification (mastectomy); however, the associated confidence intervals were mostly very wide.

Conclusion

The results of this study provide limited support for associations of the DCIS clinicopathologic characteristics studied here and risk of IBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCarcinoma, Intraductal, NoninfiltratingHumansFemaleMiddle AgedCase-Control StudiesAgedAdultRisk FactorsErb-b2 Receptor Tyrosine KinasesNeoplasm InvasivenessReceptors, EstrogenReceptors, ProgesteroneCohort StudiesNeoplasm Grading

Stichwörter der Autor:innen

ClinicopathologicDuctal carcinoma in situInvasive breast cancerRisk factors

Substanzen

Erb-b2 Receptor Tyrosine KinasesReceptors, EstrogenReceptors, Progesterone

Autor:innen und Institutionen

  • Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA. thomas.rohan@einsteinmed.edu.
  • Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center, Warren Alpert Medical School of Brown University, Providence, RI, USA.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
  • Institute for Health Research, Kaiser Permanente, Aurora, CO, USA.
  • Center for Clinical Epidemiology and Population Health, Marshfield Clinic Research Institute, Marshfield, WI, USA.

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • National Cancer Institute/National Institutes of Health
  • Breast Cancer Research Foundation

Zitieren

APA

Rohan, T. E., Wang, Y., Couch, F., Feigelson, H. S., Greenlee, R. T., Honda, S., Stark, A., Chitale, D., Zhang, C., Xue, X., Ginsberg, M., & Loudig, O. (2025). Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort study. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07599-x

Vancouver

Rohan TE, Wang Y, Couch F, Feigelson HS, Greenlee RT, Honda S, et al. Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort study. Breast Cancer Research and Treatment. 2025. doi:10.1007/s10549-024-07599-x

BibTeX
@article{Rohan2025,
  author = {Rohan, Thomas E and Wang, Yihong and Couch, Fergus and Feigelson, Heather Spencer and Greenlee, Robert T and Honda, Stacey and Stark, Azadeh and Chitale, Dhananjay and Zhang, Chenxin and Xue, Xiaonan and Ginsberg, Mindy and Loudig, Olivier},
  title = {Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort study},
  journal = {Breast Cancer Research and Treatment},
  year = {2025},
  doi = {10.1007/s10549-024-07599-x}
}
Kostenlos starten →